We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$7.49B
AUM Growth
+$381M
Cap. Flow
-$168M
Cap. Flow %
-2.25%
Top 10 Hldgs %
11.97%
Holding
386
New
15
Increased
64
Reduced
279
Closed
9

Sector Composition

Rank Sector Weight
1 Industrials 16.68%
2 Technology 15.03%
3 Healthcare 13.83%
4 Financials 13.24%
5 Consumer Discretionary 13.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCH icon
226
Banco de Chile
BCH
$20.7B
$6.57M 0.09%
313,062
-34,105
-10% -$830K
BRKR icon
227
Bruker
BRKR
$8.69B
$6.39M 0.09%
125,281
-6,117
-5% -$291K
FORR icon
228
Forrester Research
FORR
$225M
$6.15M 0.08%
147,460
-7,438
-5% -$277K
GWPH
229
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.88M 0.08%
56,193
+18,448
+49% +$2.07M
THR
230
DELISTED
Thermon Group Holdings
THR
$5.77M 0.08%
215,403
-10,172
-5% -$256K
GRBK icon
231
Green Brick Partners
GRBK
$3.08B
$5.75M 0.08%
501,345
-32,159
-6% -$351K
FOLD
232
DELISTED
Amicus Therapeutics
FOLD
$5.65M 0.08%
580,299
-31,979
-5% -$293K
NOAH
233
Noah Holdings
NOAH
$591M
$5.63M 0.08%
159,239
-17,420
-10% -$532K
IART icon
234
Integra LifeSciences
IART
$1.35B
$5.58M 0.07%
+95,686
New +$5.7M
ARNA
235
DELISTED
Arena Pharmaceuticals Inc
ARNA
$5.47M 0.07%
+120,363
New +$5.69M
CCMP
236
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$5.46M 0.07%
37,852
-14,475
-28% -$2.05M
CLDR
237
DELISTED
Cloudera, Inc.
CLDR
$5.29M 0.07%
454,800
-29,150
-6% -$279K
TPL icon
238
Texas Pacific Land
TPL
$25.2B
$5.21M 0.07%
+60,039
New +$4.39M
ATHM icon
239
Autohome
ATHM
$2.65B
$5.19M 0.07%
64,914
-3,815
-6% -$297K
ECPG icon
240
Encore Capital Group
ECPG
$1.98B
$5.09M 0.07%
144,015
-7,360
-5% -$257K
NSSC icon
241
Napco Security Technologies
NSSC
$1.42B
$5.08M 0.07%
345,902
-22,356
-6% -$324K
EPAY
242
DELISTED
Bottomline Technologies Inc
EPAY
$5.05M 0.07%
94,290
-4,698
-5% -$214K
LEGH icon
243
Legacy Housing
LEGH
$688M
$5M 0.07%
300,287
-73,832
-20% -$1.16M
BWB icon
244
Bridgewater Bancshares
BWB
$605M
$4.83M 0.06%
350,677
-22,514
-6% -$285K
EQC
245
DELISTED
Equity Commonwealth
EQC
$4.79M 0.06%
145,782
-9,473
-6% -$304K
HWKN icon
246
Hawkins
HWKN
$2.71B
$4.65M 0.06%
203,034
-13,186
-6% -$279K
MLR icon
247
Miller Industries
MLR
$620M
$4.62M 0.06%
124,397
-65,349
-34% -$2.3M
PGC icon
248
Peapack-Gladstone Financial
PGC
$806M
$4.57M 0.06%
147,910
-9,547
-6% -$281K
MSA icon
249
Mine Safety
MSA
$7.44B
$4.54M 0.06%
35,958
-15,940
-31% -$1.92M
CCF
250
DELISTED
Chase Corporation
CCF
$4.52M 0.06%
+38,158
New +$4.43M

Similar funds

GW&K Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, GW&K Investment Management held 386 positions worth $7.49B, up 5.4% from $7.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GW&K Investment Management's Q4 2019 filing shows 15 new, 64 increased, 279 reduced and 9 closed positions. Its largest new stake was Veracyte: 1,020,082 shares worth $28.5M. The largest sale was Cambrex Corporation, an estimated $27.1M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q4 2019 buy was Veracyte: 1,020,082 shares worth $28.5M.
  • GW&K Investment Management added most to Ollie's Bargain Outlet in Q4 2019, an estimated $23.3M increase.
  • GW&K Investment Management's biggest Q4 2019 reduction was TSMC, cutting an estimated $25.2M.
  • GW&K Investment Management fully exited Cambrex Corporation in Q4 2019, selling an estimated $27.1M.
  • GW&K Investment Management's ten largest holdings make up 12% of its $7.49B portfolio in Q4 2019.
  • GW&K Investment Management opened 15 new positions and closed 9 in Q4 2019.
  • GW&K Investment Management's portfolio value rose 5.4% quarter-over-quarter to $7.49B.

Based on GW&K Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.